More than 220 organizations, including the AHA, Friday urged Senate committee leaders to consider the Overdose Prevention and Patient Safety Act (H.R. 6082) and encourage Senate leadership to bring the bill to the floor for a vote during the lame-duck session. The House-passed bill would align federal regulations governing the confidentiality of drug and alcohol treatment and prevention records with the Health Insurance Portability and Accountability Act and strengthen consumer protections. “Modifying Part 2 to ensure that HIPAA-covered entities have access to a patient’s medical record will improve patient safety, treatment and outcomes across the care delivery spectrum, enhancing the entire opioid package passed by the House and Senate,” the organizations said in a letter to leaders of the Senate Health, Education, Labor and Pensions Committee.

Related News Articles

Headline
The Substance Abuse and Mental Health Services Administration today released a proposed rule that would amend federal regulations regarding disclosure of…
Headline
The number of U.S. residents misusing pain relievers fell by 11% in 2018, to about 9.9 million, according to the latest National Survey on Drug Use and Health…
Headline
The U.S. Preventative Services Task Force yesterday released for comment a draft recommendation that primary care clinicians screen all adults for illicit drug…
Headline
The Health Resources and Services Administration yesterday awarded 80 rural consortia $1 million each to help prevent, treat and support recovery for patients…
Headline
The AHA yesterday voiced support for the Competitive Health Insurance Reform Act (H.R. 1418/S. 350), legislation that would repeal the antitrust exemption…
Headline
The AHA today voiced support for the Improving Seniors’ Timely Access to Care Act (H.R. 3107), bipartisan legislation that would establish requirements for the…